When a thymic carcinoma ``becomes'' a GIST (Englisch)
- Neue Suche nach: Rossi, V.
- Neue Suche nach: Donini, M.
- Neue Suche nach: Sergio, P.
- Neue Suche nach: Passalacqua, R.
- Neue Suche nach: Rossi, G.
- Neue Suche nach: Buti, S.
- Neue Suche nach: Rossi, V.
- Neue Suche nach: Donini, M.
- Neue Suche nach: Sergio, P.
- Neue Suche nach: Passalacqua, R.
- Neue Suche nach: Rossi, G.
- Neue Suche nach: Buti, S.
In:
LUNG CANCER -AMSTERDAM-
;
80
, 1
;
106-108
;
2013
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:When a thymic carcinoma ``becomes'' a GIST
-
Beteiligte:Rossi, V. ( Autor:in ) / Donini, M. ( Autor:in ) / Sergio, P. ( Autor:in ) / Passalacqua, R. ( Autor:in ) / Rossi, G. ( Autor:in ) / Buti, S. ( Autor:in )
-
Erschienen in:LUNG CANCER -AMSTERDAM- ; 80, 1 ; 106-108
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2013
-
Format / Umfang:3 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.99424
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.99424 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 80, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Transformation to ``high grade'' neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinomaPopat, S. / Wotherspoon, A. / Nutting, C.M. / Gonzalez, D. / Nicholson, A.G. / O Brien, M. et al. | 2013
- 5
-
Accuracy of sentinel node biopsy in the staging of non-small cell lung carcinomas: Systematic review and meta-analysis of the literatureKermani, A.T. / Bagheri, R. / Tehranian, S. / Shojaee, P. / Sadeghi, R. / Krag, D.N. et al. | 2013
- 15
-
Farletuzumab in lung cancerThomas, A. / Maltzman, J. / Hassan, R. et al. | 2013
- 19
-
Mesenchymal stem cells in non-small cell lung cancer-Different from others? Insights from comparative molecular and functional analysesGottschling, S. / Granzow, M. / Kuner, R. / Jauch, A. / Herpel, E. / Xu, E.C. / Muley, T. / Schnabel, P.A. / Herth, F.J.F. / Meister, M. et al. | 2013
- 30
-
Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancerEsterbrook, G. / Anathhanam, S. / Plant, P.K. et al. | 2013
- 35
-
Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancerBozzetti, C. / Naldi, N. / Nizzoli, R. / Azzoni, C. / Bortesi, B. / Zobbi, V. / Bottarelli, L. / Tiseo, M. / Gasparro, D. / Majori, M. et al. | 2013
- 39
-
Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?Creaney, J. / Dick, I.M. / Dare, H. / Demelker, Y. / Nowak, A.K. / Musk, A.W. / Robinson, B.W.S. et al. | 2013
- 45
-
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancerOkamura, K. / Takayama, K. / Izumi, M. / Harada, T. / Furuyama, K. / Nakanishi, Y. et al. | 2013
- 50
-
Assessment of lung cancer mortality reduction after chest X-ray screening in smokers: A population-based cohort study in Varese, ItalyDominioni, L. / Poli, A. / Mantovani, W. / Pisani, S. / Rotolo, N. / Paolucci, M. / Sessa, F. / Conti, V. / D Ambrosio, V. / Paddeu, A. et al. | 2013
- 55
-
Factors associated with smoking abstinence after diagnosis of early stage lung cancerHopenhayn, C. / Christian, W.J. / Christian, A. / Studts, J. / Mullet, T. et al. | 2013
- 62
-
Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancerWiersma, T.G. / Dahele, M. / Verbakel, W.F.A.R. / van de Ven, P.M. / de Haan, P.F. / Smit, E.F. / van Reij, E.J.F. / Slotman, B.J. / Senan, S. et al. | 2013
- 68
-
Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancerMornex, F. / Peignaux, K. / Germain, T. / Wautot, V. / Chouaki, N. et al. | 2013
- 75
-
Clinical outcomes with chemotherapy for advanced thymic carcinomaOkuma, Y. / Hosomi, Y. / Takagi, Y. / Sasaki, E. / Hishima, T. / Maeda, Y. / Shibuya, M. / Okamura, T. et al. | 2013
- 81
-
A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable?Bourayou, N. / Tourani, J.-M. / Demierre, N. / Zoete, V. / Michielin, O. / Stauffer, E. / Zimmermann, D.R. / Betticher, D.C. / Peters, S. et al. | 2013
- 85
-
Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancerTakeshita, M. / Koga, T. / Takayama, K. / Ijichi, K. / Yano, T. / Maehara, Y. / Nakanishi, Y. / Sueishi, K. et al. | 2013
- 91
-
Network-based approach identified cell cycle genes as predictor of overall survival in lung adenocarcinoma patientsLi, Y. / Tang, H. / Sun, Z. / Bungum, A.O. / Edell, E.S. / Lingle, W.L. / Stoddard, S.M. / Zhang, M. / Jen, J. / Yang, P. et al. | 2013
- 99
-
Solitary pulmonary metastasis from lung cancer harboring EML4-ALK after a 15-year disease-free intervalTomizawa, K. / Ito, S. / Suda, K. / Fukui, T. / Usami, N. / Hatooka, S. / Kuwano, H. / Yatabe, Y. / Mitsudomi, T. et al. | 2013
- 102
-
High-dose, pulsatile erlotinib in two NSCLC patients with leptomeningeal metastases-One with a remarkable thoracic response as wellKuiper, J.L. / Smit, E.F. et al. | 2013
- 106
-
When a thymic carcinoma ``becomes'' a GISTRossi, V. / Donini, M. / Sergio, P. / Passalacqua, R. / Rossi, G. / Buti, S. et al. | 2013
- 109
-
Long-term gefitinib treatment of occult lung carcinoma with multiple brain metastasesKobayashi, T. / Takeda, M. / Marumo, S. / Koshimo, Y. / Teranishi, T. / Higami, Y. / Kato, M. et al. | 2013
- 111
-
Continuous pemetrexed treatment for brain metastasis in non-small cell lung cancer-A report of two casesOchi, N. / Yamane, H. / Yamagishi, T. / Takigawa, N. et al. | 2013
- 113
-
First case report of intrathecal panitumumab for treatment of meningeal carcinomatousis in an EGFR mutant lung adenocarcinoma patientHollebecque, A. / Levy, A. / Broutin, S. / Lemare, F. / Gazzah, A. / Desmaris, R. / Chenailler, C. / Elbaum, M. / Besse, B. / Paci, A. et al. | 2013